Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 26 July, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 532538 | NSE: ULTRACEMCO

UltraTech Cement Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: July 26, 2025, 1:39 pm

Market Cap 3,60,982 Cr.
Current Price 12,250
High / Low 12,714/10,048
Stock P/E52.2
Book Value 2,399
Dividend Yield0.63 %
ROCE10.9 %
ROE9.34 %
Face Value 10.0
PEG Ratio-33.60

Quick Insight

UltraTech Cement Ltd, trading at ₹12,250 with a market capitalization of ₹3,60,982 crore, showcases a robust financial profile, highlighted by a P/E ratio of 52.2 and a return on equity (ROE) of 9.34%. The company maintains a healthy operating profit margin (OPM) of 20% and a return on capital employed (ROCE) of 10.9%, indicating efficient capital utilization. With net profits of ₹6,040 crore and reserves of ₹70,412 crore against borrowings of ₹24,102 crore, UltraTech demonstrates solid financial stability, evidenced by an interest coverage ratio (ICR) of 8.06x. Given its significant promoter holding of 59.99% and a diverse shareholder base, UltraTech is well-positioned for sustained growth, making it a compelling investment choice for those seeking exposure in the cement sector.

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for UltraTech Cement Ltd

Competitors of UltraTech Cement Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Bheema Cements Ltd 52.7 Cr. 16.2 30.6/16.2 3.950.00 %13.1 %108 % 10.0
UltraTech Cement Ltd 3,60,982 Cr. 12,250 12,714/10,04852.2 2,3990.63 %10.9 %9.34 % 10.0
The Ramco Cements Ltd 27,034 Cr. 1,144 1,199/778237 3170.17 %4.83 %1.56 % 1.00
The India Cements Ltd 11,511 Cr. 371 386/239 3290.00 %4.22 %7.15 % 10.0
Star Cement Ltd 9,585 Cr. 238 248/17256.8 71.20.00 %8.38 %6.04 % 1.00
Industry Average38,653.26 Cr2,176.8060.87557.100.50%8.49%85.80%7.13

All Competitor Stocks of UltraTech Cement Ltd

Quarterly Result

MetricMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
Sales 15,76715,16413,89315,52118,66217,73716,01216,74020,41918,07015,63517,77923,063
Expenses 12,69512,06912,02813,18515,34014,68813,46113,48516,30515,03013,61814,88518,456
Operating Profit 3,0733,0951,8652,3363,3223,0492,5513,2554,1143,0392,0172,8934,608
OPM % 19%20%13%15%18%17%16%19%20%17%13%16%20%
Other Income 2531101461301231771711467320122124793
Interest 206216200215191211234262261256317457475
Depreciation 7036957087237627497987838158439049931,125
Profit before tax 2,4162,2931,1031,5272,4922,2671,6902,3553,1112,1421,0171,6913,101
Tax % -8%31%31%30%33%25%24%25%27%21%19%19%20%
Net Profit 2,6141,5827591,0631,6701,6901,2801,7752,2591,6958251,3632,475
EPS in Rs 90.7854.8726.1836.6657.7158.4944.3961.5578.2258.7728.4047.0984.23

Last Updated: May 31, 2025, 7:26 am

Below is a detailed analysis of the quarterly data for UltraTech Cement Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Sales, as of Mar 2025, the value is 23,063.00 Cr.. The value appears strong and on an upward trend. It has increased from 17,779.00 Cr. (Dec 2024) to 23,063.00 Cr., marking an increase of 5,284.00 Cr..
  • For Expenses, as of Mar 2025, the value is 18,456.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14,885.00 Cr. (Dec 2024) to 18,456.00 Cr., marking an increase of 3,571.00 Cr..
  • For Operating Profit, as of Mar 2025, the value is 4,608.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,893.00 Cr. (Dec 2024) to 4,608.00 Cr., marking an increase of 1,715.00 Cr..
  • For OPM %, as of Mar 2025, the value is 20.00%. The value appears strong and on an upward trend. It has increased from 16.00% (Dec 2024) to 20.00%, marking an increase of 4.00%.
  • For Other Income, as of Mar 2025, the value is 93.00 Cr.. The value appears to be declining and may need further review. It has decreased from 247.00 Cr. (Dec 2024) to 93.00 Cr., marking a decrease of 154.00 Cr..
  • For Interest, as of Mar 2025, the value is 475.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 457.00 Cr. (Dec 2024) to 475.00 Cr., marking an increase of 18.00 Cr..
  • For Depreciation, as of Mar 2025, the value is 1,125.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 993.00 Cr. (Dec 2024) to 1,125.00 Cr., marking an increase of 132.00 Cr..
  • For Profit before tax, as of Mar 2025, the value is 3,101.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,691.00 Cr. (Dec 2024) to 3,101.00 Cr., marking an increase of 1,410.00 Cr..
  • For Tax %, as of Mar 2025, the value is 20.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Dec 2024) to 20.00%, marking an increase of 1.00%.
  • For Net Profit, as of Mar 2025, the value is 2,475.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,363.00 Cr. (Dec 2024) to 2,475.00 Cr., marking an increase of 1,112.00 Cr..
  • For EPS in Rs, as of Mar 2025, the value is 84.23. The value appears strong and on an upward trend. It has increased from 47.09 (Dec 2024) to 84.23, marking an increase of 37.14.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:48 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 20,73023,30625,15325,37530,97941,46242,43044,72652,59963,24070,90875,95577,752
Expenses 16,69518,88120,25220,16224,83434,11533,18433,15841,08452,62057,94063,40863,828
Operating Profit 4,0354,4254,9015,2126,1457,3479,24611,56811,51410,62012,96912,54713,924
OPM % 19%19%19%21%20%18%22%26%22%17%18%17%18%
Other Income 322350464648242350651619669507567647703
Interest 3615875666401,2381,7781,9921,4869458239681,6511,682
Depreciation 1,1391,2031,3771,3481,8482,4512,7232,7002,7152,8883,1454,0154,128
Profit before tax 2,8582,9863,4213,8723,3013,4685,1838,0018,5247,4169,4227,5288,816
Tax % 23%30%28%30%33%31%-11%32%14%32%26%20%
Net Profit 2,2132,1022,4802,7142,2242,4005,7515,4627,3345,0737,0046,0406,884
EPS in Rs 80.4476.4790.3098.9080.9287.51199.40189.26254.42175.41242.65204.94235.26
Dividend Payout % 11%12%11%10%13%13%7%20%15%22%29%38%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-5.02%17.98%9.44%-18.05%7.91%139.62%-5.03%34.27%-30.83%38.06%-13.76%
Change in YoY Net Profit Growth (%)0.00%23.00%-8.55%-27.49%25.97%131.71%-144.65%39.30%-65.10%68.89%-51.83%

UltraTech Cement Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:13%
5 Years:12%
3 Years:13%
TTM:8%
Compounded Profit Growth
10 Years:12%
5 Years:1%
3 Years:-5%
TTM:0%
Stock Price CAGR
10 Years:15%
5 Years:26%
3 Years:23%
1 Year:5%
Return on Equity
10 Years:12%
5 Years:12%
3 Years:10%
Last Year:9%

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 2:31 pm

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital 274274274275275275289289289289289295
Reserves 16,90818,76721,67124,11726,10733,47638,75543,88650,14754,03659,93970,412
Borrowings 7,3329,82910,6168,47419,48025,33723,01921,71911,29911,05811,40324,102
Other Liabilities 7,6719,1838,6319,34311,28017,43817,15120,28222,07725,99829,16738,888
Total Liabilities 32,18538,05341,19342,20957,14176,52579,21486,17683,81191,380100,797133,697
Fixed Assets 18,10023,34325,30925,90439,71556,64557,15155,41255,48859,57962,87894,610
CWIP 2,1862,2501,4699211,5111,1539201,6874,7854,0406,8116,188
Investments 4,8624,5005,0956,6915,4472,9215,92912,1786,3367,2978,2495,156
Other Assets 7,0377,9619,3198,69310,46815,80615,21516,90017,20320,46422,85927,742
Total Assets 32,18538,05341,19342,20957,14176,52579,21486,17683,81191,380100,797133,697

Below is a detailed analysis of the balance sheet data for UltraTech Cement Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Mar 2025, the value is 295.00 Cr.. The value appears strong and on an upward trend. It has increased from 289.00 Cr. (Mar 2024) to 295.00 Cr., marking an increase of 6.00 Cr..
  • For Reserves, as of Mar 2025, the value is 70,412.00 Cr.. The value appears strong and on an upward trend. It has increased from 59,939.00 Cr. (Mar 2024) to 70,412.00 Cr., marking an increase of 10,473.00 Cr..
  • For Borrowings, as of Mar 2025, the value is 24,102.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 11,403.00 Cr. (Mar 2024) to 24,102.00 Cr., marking an increase of 12,699.00 Cr..
  • For Other Liabilities, as of Mar 2025, the value is 38,888.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29,167.00 Cr. (Mar 2024) to 38,888.00 Cr., marking an increase of 9,721.00 Cr..
  • For Total Liabilities, as of Mar 2025, the value is 133,697.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 100,797.00 Cr. (Mar 2024) to 133,697.00 Cr., marking an increase of 32,900.00 Cr..
  • For Fixed Assets, as of Mar 2025, the value is 94,610.00 Cr.. The value appears strong and on an upward trend. It has increased from 62,878.00 Cr. (Mar 2024) to 94,610.00 Cr., marking an increase of 31,732.00 Cr..
  • For CWIP, as of Mar 2025, the value is 6,188.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6,811.00 Cr. (Mar 2024) to 6,188.00 Cr., marking a decrease of 623.00 Cr..
  • For Investments, as of Mar 2025, the value is 5,156.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8,249.00 Cr. (Mar 2024) to 5,156.00 Cr., marking a decrease of 3,093.00 Cr..
  • For Other Assets, as of Mar 2025, the value is 27,742.00 Cr.. The value appears strong and on an upward trend. It has increased from 22,859.00 Cr. (Mar 2024) to 27,742.00 Cr., marking an increase of 4,883.00 Cr..
  • For Total Assets, as of Mar 2025, the value is 133,697.00 Cr.. The value appears strong and on an upward trend. It has increased from 100,797.00 Cr. (Mar 2024) to 133,697.00 Cr., marking an increase of 32,900.00 Cr..

Notably, the Reserves (70,412.00 Cr.) exceed the Borrowings (24,102.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +3,4554,1904,5265,0053,8885,9568,97212,5009,2839,06910,89810,673
Cash from Investing Activity +-2,342-2,144-3,673-2,5011,8661,165-4,192-8,8562,257-7,188-8,789-16,504
Cash from Financing Activity +-949-2,110-844-2,535-5,735-6,757-5,076-4,356-12,498-1,631-1,9265,076
Net Cash Flow164-638-3118364-295-712-958250183-755

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-3.00-5.00-6.00-3.00-13.00-18.00-14.00-10.000.00-1.001.00-12.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days242926282526252021212222
Inventory Days284251266203195226214234207256248255
Days Payable258252154142150165165188234269271260
Cash Conversion Cycle50281388970877466-69-017
Working Capital Days-15-2-42-47-23-17-16-25-26-21-29-25
ROCE %19%12%12%13%14%12%10%12%15%14%13%15%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
Promoters59.96%59.96%59.96%59.96%59.96%59.96%59.96%59.96%59.96%59.96%59.98%59.99%
FIIs15.74%14.03%13.12%14.06%14.11%14.77%15.81%16.65%18.20%17.74%18.15%17.95%
DIIs15.15%16.39%18.16%17.30%17.40%16.93%15.95%15.04%13.68%14.14%13.83%14.08%
Government0.05%0.05%0.05%0.05%0.05%0.05%0.05%0.05%0.05%0.05%0.05%0.05%
Public9.00%9.48%8.62%8.50%8.35%8.14%8.09%8.11%7.95%7.92%7.82%7.75%
Others0.10%0.09%0.09%0.14%0.13%0.15%0.14%0.18%0.18%0.17%0.17%0.17%
No. of Shareholders3,31,3193,95,9724,33,1964,15,4033,83,9713,66,4373,49,2813,47,9043,42,4223,57,6273,53,5653,56,405

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Bluechip Fund 2,150,633 4.23 2509.342,150,6332025-04-22 17:25:170%
SBI Nifty 50 ETF 2,098,537 1.26 2448.552,098,5372025-04-22 17:25:170%
Kotak Flexicap Fund - Regular Plan 1,800,000 4.11 2100.221,800,0002025-04-22 14:53:350%
SBI BSE Sensex ETF 1,508,539 1.48 1759.151,508,5392025-04-22 17:25:170%
Axis Bluechip Fund 691,368 2.34 806.68691,3682025-04-22 11:41:350%
SBI Blue Chip Fund 641,261 1.52 748.22641,2612025-04-22 17:25:170%
UTI Nifty 50 ETF 606,472 1.26 707.63606,4722025-04-22 17:25:170%
UTI BSE Sensex ETF 552,023 1.48 643.73552,0232025-04-22 17:25:170%
ICICI Prudential Balanced Advantage Fund 519,826 1.04 606.53519,8262025-04-22 17:25:170%
ICICI Prudential Business Cycle Fund 486,998 5.21 568.22486,9982025-04-22 17:25:170%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 205.30243.05175.63254.64189.40
Diluted EPS (Rs.) 205.13242.87175.54254.53189.33
Cash EPS (Rs.) 341.56350.80275.64348.06282.69
Book Value[Excl.RevalReserv]/Share (Rs.) 2399.422088.171883.691747.051530.59
Book Value[Incl.RevalReserv]/Share (Rs.) 2399.422088.171883.691747.051530.59
Revenue From Operations / Share (Rs.) 2577.552456.202190.581822.111549.48
PBDIT / Share (Rs.) 451.39470.59385.29416.47426.19
PBIT / Share (Rs.) 315.14361.64285.25322.42332.65
PBT / Share (Rs.) 255.83325.62256.75289.70272.14
Net Profit / Share (Rs.) 205.31241.85175.60254.01189.14
NP After MI And SOA / Share (Rs.) 204.96242.65175.41254.42189.26
PBDIT Margin (%) 17.5119.1517.5822.8527.50
PBIT Margin (%) 12.2214.7213.0217.6921.46
PBT Margin (%) 9.9213.2511.7215.8917.56
Net Profit Margin (%) 7.969.848.0113.9412.20
NP After MI And SOA Margin (%) 7.959.878.0013.9612.21
Return on Networth / Equity (%) 8.5411.639.3214.5612.36
Return on Capital Employeed (%) 9.1614.1212.1114.6114.63
Return On Assets (%) 4.516.945.548.766.33
Long Term Debt / Equity (X) 0.220.080.090.100.30
Total Debt / Equity (X) 0.320.170.180.200.40
Asset Turnover Ratio (%) 0.640.730.710.600.54
Current Ratio (X) 0.730.860.880.861.17
Quick Ratio (X) 0.430.550.600.590.97
Inventory Turnover Ratio (X) 1.321.371.461.411.31
Dividend Payout Ratio (NP) (%) 0.0015.6321.5714.526.86
Dividend Payout Ratio (CP) (%) 0.0010.7813.7410.604.59
Earning Retention Ratio (%) 0.0084.3778.4385.4893.14
Cash Earning Retention Ratio (%) 0.0089.2286.2689.4095.41
Interest Coverage Ratio (X) 8.0614.0313.5212.738.28
Interest Coverage Ratio (Post Tax) (X) 4.728.297.168.594.75
Enterprise Value (Cr.) 363558.87290900.97228788.60200424.86210253.91
EV / Net Operating Revenue (X) 4.794.103.623.814.70
EV / EBITDA (X) 27.3321.4120.5716.6717.09
MarketCap / Net Operating Revenue (X) 4.463.973.483.624.35
Retention Ratios (%) 0.0084.3678.4285.4793.13
Price / BV (X) 4.794.674.053.784.40
Price / Net Operating Revenue (X) 4.463.973.483.624.35
EarningsYield 0.010.020.020.030.02

After reviewing the key financial ratios for UltraTech Cement Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 205.30. This value is within the healthy range. It has decreased from 243.05 (Mar 24) to 205.30, marking a decrease of 37.75.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 205.13. This value is within the healthy range. It has decreased from 242.87 (Mar 24) to 205.13, marking a decrease of 37.74.
  • For Cash EPS (Rs.), as of Mar 25, the value is 341.56. This value is within the healthy range. It has decreased from 350.80 (Mar 24) to 341.56, marking a decrease of 9.24.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,399.42. It has increased from 2,088.17 (Mar 24) to 2,399.42, marking an increase of 311.25.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,399.42. It has increased from 2,088.17 (Mar 24) to 2,399.42, marking an increase of 311.25.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,577.55. It has increased from 2,456.20 (Mar 24) to 2,577.55, marking an increase of 121.35.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 451.39. This value is within the healthy range. It has decreased from 470.59 (Mar 24) to 451.39, marking a decrease of 19.20.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 315.14. This value is within the healthy range. It has decreased from 361.64 (Mar 24) to 315.14, marking a decrease of 46.50.
  • For PBT / Share (Rs.), as of Mar 25, the value is 255.83. This value is within the healthy range. It has decreased from 325.62 (Mar 24) to 255.83, marking a decrease of 69.79.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 205.31. This value is within the healthy range. It has decreased from 241.85 (Mar 24) to 205.31, marking a decrease of 36.54.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 204.96. This value is within the healthy range. It has decreased from 242.65 (Mar 24) to 204.96, marking a decrease of 37.69.
  • For PBDIT Margin (%), as of Mar 25, the value is 17.51. This value is within the healthy range. It has decreased from 19.15 (Mar 24) to 17.51, marking a decrease of 1.64.
  • For PBIT Margin (%), as of Mar 25, the value is 12.22. This value is within the healthy range. It has decreased from 14.72 (Mar 24) to 12.22, marking a decrease of 2.50.
  • For PBT Margin (%), as of Mar 25, the value is 9.92. This value is below the healthy minimum of 10. It has decreased from 13.25 (Mar 24) to 9.92, marking a decrease of 3.33.
  • For Net Profit Margin (%), as of Mar 25, the value is 7.96. This value is within the healthy range. It has decreased from 9.84 (Mar 24) to 7.96, marking a decrease of 1.88.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.95. This value is below the healthy minimum of 8. It has decreased from 9.87 (Mar 24) to 7.95, marking a decrease of 1.92.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 8.54. This value is below the healthy minimum of 15. It has decreased from 11.63 (Mar 24) to 8.54, marking a decrease of 3.09.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 9.16. This value is below the healthy minimum of 10. It has decreased from 14.12 (Mar 24) to 9.16, marking a decrease of 4.96.
  • For Return On Assets (%), as of Mar 25, the value is 4.51. This value is below the healthy minimum of 5. It has decreased from 6.94 (Mar 24) to 4.51, marking a decrease of 2.43.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has increased from 0.08 (Mar 24) to 0.22, marking an increase of 0.14.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has increased from 0.17 (Mar 24) to 0.32, marking an increase of 0.15.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has decreased from 0.73 (Mar 24) to 0.64, marking a decrease of 0.09.
  • For Current Ratio (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1.5. It has decreased from 0.86 (Mar 24) to 0.73, marking a decrease of 0.13.
  • For Quick Ratio (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.55 (Mar 24) to 0.43, marking a decrease of 0.12.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 4. It has decreased from 1.37 (Mar 24) to 1.32, marking a decrease of 0.05.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 15.63 (Mar 24) to 0.00, marking a decrease of 15.63.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 10.78 (Mar 24) to 0.00, marking a decrease of 10.78.
  • For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 84.37 (Mar 24) to 0.00, marking a decrease of 84.37.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 89.22 (Mar 24) to 0.00, marking a decrease of 89.22.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 8.06. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 8.06, marking a decrease of 5.97.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.72. This value is within the healthy range. It has decreased from 8.29 (Mar 24) to 4.72, marking a decrease of 3.57.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 363,558.87. It has increased from 290,900.97 (Mar 24) to 363,558.87, marking an increase of 72,657.90.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.79. This value exceeds the healthy maximum of 3. It has increased from 4.10 (Mar 24) to 4.79, marking an increase of 0.69.
  • For EV / EBITDA (X), as of Mar 25, the value is 27.33. This value exceeds the healthy maximum of 15. It has increased from 21.41 (Mar 24) to 27.33, marking an increase of 5.92.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.46. This value exceeds the healthy maximum of 3. It has increased from 3.97 (Mar 24) to 4.46, marking an increase of 0.49.
  • For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 84.36 (Mar 24) to 0.00, marking a decrease of 84.36.
  • For Price / BV (X), as of Mar 25, the value is 4.79. This value exceeds the healthy maximum of 3. It has increased from 4.67 (Mar 24) to 4.79, marking an increase of 0.12.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.46. This value exceeds the healthy maximum of 3. It has increased from 3.97 (Mar 24) to 4.46, marking an increase of 0.49.
  • For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of UltraTech Cement Ltd as of July 26, 2025 is: 9,415.97

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of July 26, 2025, UltraTech Cement Ltd is Overvalued by 23.13% compared to the current share price 12,250.00

Intrinsic Value of UltraTech Cement Ltd as of July 26, 2025 is: 9,269.67

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of July 26, 2025, UltraTech Cement Ltd is Overvalued by 24.33% compared to the current share price 12,250.00

Last 5 Year EPS CAGR: -1.55%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a low average Working Capital Days of -24.00, which is a positive sign.
  2. The company has higher reserves (38,185.08 cr) compared to borrowings (15,305.67 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (45.15 cr) and profit (5.23 cr) over the years.
  1. The stock has a low average ROCE of 13.42%, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 51.83, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in UltraTech Cement Ltd:
    1. Net Profit Margin: 7.96%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 9.16% (Industry Average ROCE: 8.21%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 8.54% (Industry Average ROE: 80.08%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 4.72
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.43
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 52.2 (Industry average Stock P/E: 36.52)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.32
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

UltraTech Cement Ltd. is a Public Limited Listed company incorporated on 24/08/2000 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L26940MH2000PLC128420 and registration number is 128420. Currently Company is involved in the business activities of Manufacture of cement, lime and plaster. Company's Total Operating Revenue is Rs. 71894.97 Cr. and Equity Capital is Rs. 294.68 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Cement'B' Wing, Ahura Centre, 2nd Foor, Mumbai Maharashtra 400093sharesutcl@adityabirla.com
http://www.ultratechcement.com
Management
NamePosition Held
Mr. Kumar Mangalam BirlaChairman
Mr. K K MaheshwariVice Chairman & Non Exe.Dire
Mr. K C JhanwarManaging Director
Mr. Atul DagaWholeTime Director & CFO
Mrs. Rajashree BirlaNon Executive Director
Mr. Arun AdhikariIndependent Director
Mrs. Alka BharuchaIndependent Director
Mr. Sunil DuggalIndependent Director
Mrs. Sukanya KripaluIndependent Director
Mr. S B MathurIndependent Director

FAQ

What is the intrinsic value of UltraTech Cement Ltd?

UltraTech Cement Ltd's intrinsic value (as of 26 July 2025) is 9415.97 23.13% lower the current market price of 12,250.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,60,982 Cr. market cap, FY2025-2026 high/low of 12,714/10,048, reserves of 70,412 Cr, and liabilities of 133,697 Cr.

What is the Market Cap of UltraTech Cement Ltd?

The Market Cap of UltraTech Cement Ltd is 3,60,982 Cr..

What is the current Stock Price of UltraTech Cement Ltd as on 26 July 2025?

The current stock price of UltraTech Cement Ltd as on 26 July 2025 is 12,250.

What is the High / Low of UltraTech Cement Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of UltraTech Cement Ltd stocks is ₹12,714/10,048.

What is the Stock P/E of UltraTech Cement Ltd?

The Stock P/E of UltraTech Cement Ltd is 52.2.

What is the Book Value of UltraTech Cement Ltd?

The Book Value of UltraTech Cement Ltd is 2,399.

What is the Dividend Yield of UltraTech Cement Ltd?

The Dividend Yield of UltraTech Cement Ltd is 0.63 %.

What is the ROCE of UltraTech Cement Ltd?

The ROCE of UltraTech Cement Ltd is 10.9 %.

What is the ROE of UltraTech Cement Ltd?

The ROE of UltraTech Cement Ltd is 9.34 %.

What is the Face Value of UltraTech Cement Ltd?

The Face Value of UltraTech Cement Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in UltraTech Cement Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore More Stocks